Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 30 Sep ‘21 |
|
|---|---|---|---|---|---|
| $5.88M | $11.6M | $5.73M | 25.7% |
|
|
| $5.87M | $14.6M | $8.76M | 3.89% |
|
|
| $5.82M | $8.39M | $2.57M | 41.6% |
|
|
879
Arbutus Biopharma
ABUS
$894M
| $5.81M | $13.5M | $7.71M | 8.39% |
|
| $5.81M | $7.26M | $1.46M | 88.4% |
|
|
| $5.79M | $33.9M | $28.1M | 43.1% |
|
|
| $5.78M | $9.77M | $3.99M | 83.2% |
|
|
| $5.75M | $10.3M | $4.57M | 46.9% |
|
|
| $5.73M | $17.4M | $11.6M | 4.43% |
|
|
| $5.73M | $40.1M | $34.4M | 86.1% |
|
|
886
Manhattan Associates
MANH
$8.09B
| $5.73M | $11.1M | $5.38M | 11.7% |
|
| $5.71M | $21.2M | $15.5M | 63.4% |
|
|
| $5.71M | $115M | $109M | 91.7% |
|
|
| $5.68M | $22.1M | $16.4M | 89.2% |
|
|
| $5.6M | $8.36M | $2.76M | 83.7% |
|
|
| $5.56M | $16.8M | $11.2M | 128% |
|
|
| $5.55M | $10.1M | $4.5M | 50.5% |
|
|
| $5.55M | $10.3M | $4.74M | 71.5% |
|
|
| $5.53M | $9.16M | $3.63M | 90.4% |
|
|
| $5.53M | $10.7M | $5.18M | 83.7% |
|
|
| $5.52M | $13.7M | $8.23M | 0.81% |
|
|
| $5.47M | $11.1M | $5.67M | 224% |
|
|
| $5.45M | $65.1M | $59.6M | 3.12% |
|
|
| $5.43M | $5.64M | $204K | 53.5% |
|
|
| $5.43M | $5.43M | $2K | 28% |
|